StoneX Group’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,344
Closed -$39K 754
2023
Q2
$39K Buy
+13,344
New +$30.2K ﹤0.01% 562
2023
Q1
Sell
-49,056
Closed -$91.7K 829
2022
Q4
$91.7K Buy
+49,056
New +$76.6K 0.01% 518
2021
Q4
Sell
-19,163
Closed -$384K 611
2021
Q3
$384K Buy
+19,163
New +$495K 0.06% 305

Other funds holding RNLX

StoneX Group's RNLX Position: Q3 2023 in Review

StoneX Group sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2023, closing a stake of 13,344 shares — an estimated $39K sold.

StoneX Group first reported a position in RNLX in Q3 2021 and held it in 3 quarters. The position peaked at $384K in Q3 2021. 26 funds tracked by Wall St. Rank hold RNLX as of Q3 2023.

  • StoneX Group reported no remaining Renalytix plc American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • StoneX Group sold 13,344 Renalytix plc American Depositary Shares shares in Q3 2023, an estimated $39K.
  • StoneX Group first reported a position in Renalytix plc American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • StoneX Group's Renalytix plc American Depositary Shares position peaked at $384K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2023.

Based on StoneX Group's 13F filing for Q3 2023, filed 15 Nov 2023.